Market Closed -
Other stock markets
|
After market 03:49:32 pm | |||
25.02 EUR | -0.48% | 24.92 | -0.40% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.36% | 1.8B | |
+55.40% | 59.34B | |
+43.17% | 40.24B | |
-5.09% | 39.88B | |
-5.56% | 28.55B | |
+14.76% | 27.26B | |
-21.63% | 19.23B | |
+31.48% | 12.61B | |
+2.15% | 12.49B | |
+25.81% | 12.28B |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- RBC Cuts Price Target on Galapagos to $38 From $41, Keeps Sector Perform Rating